4d pharma (LSE:DDDD) ROE % Adjusted to Book Value : -67.30% (As of Dec. 2021)

View and export this data going back to 2014. Start your Free Trial

What is 4d pharma ROE % Adjusted to Book Value?

4d pharma's ROE % for the quarter that ended in Dec. 2021 was -279.98%. 4d pharma's PB Ratio for the quarter that ended in Dec. 2021 was 4.16. 4d pharma's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2021 was -67.30%.

4d pharma ROE % Adjusted to Book Value Historical Data

The historical data trend for 4d pharma's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

4d pharma ROE % Adjusted to Book Value Chart

4d pharma Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-8.36

-29.65

-24.19

-16.56

-50.70

4d pharma Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21
ROE % Adjusted to Book Value	Get a 7-Day Free Trial											-27.59	-68.54	-13.59	-20.47	-67.30

Competitive Comparison of 4d pharma's ROE % Adjusted to Book Value

For the Biotechnology subindustry, 4d pharma's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

4d pharma's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 4d pharma's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where 4d pharma's ROE % Adjusted to Book Value falls into.

4d pharma ROE % Adjusted to Book Value Calculation

4d pharma's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2021 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-210.91%	/	4.16
	=	-50.70%

4d pharma's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2021 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-279.98%	/	4.16
	=	-67.30%

4d pharma ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of 4d pharma's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

4d pharma (LSE:DDDD) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 4d pharma PLC (LSE:DDDD) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

9 Bond Court, Fifth Floor, Leeds, GBR, LS1 2JZ

Website

https://www.4dpharmaplc.com

4d pharma PLC and its subsidiaries are in the business of research and development and production of live biotherapeutic products. The company develops biotherapeutic products for diseases such as cancer, asthma, autism, and autoimmune conditions such as arthritis and multiple sclerosis. Its developing science includes Live biotherapeutics, Microbiome, MicroRx, MicroDx, and others.

4d pharma (LSE:DDDD) Headlines

No Headlines